Sp1189

VALUE OF THE PPI TRIAL FOR GERD SYNDROMES

Date
May 9, 2023
Explore related products in the following collection:

Society: AGA

This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice. This session will specifically focus on common clinical challenges in the realm of GERD and will include a debate on the value of PPI trial versus up-front testing for GERD.

Presenter

Speaker Image for Kerry Dunbar
Dallas VA Medical Center/University of Texas Southwestern Medical Center

Tracks

Related Products

Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA
Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for IN BARRETT’S ESOPHAGUS, REFLUX INDUCES EMT THAT MIGHT UNDERLIE THE DEVELOPMENT OF SUB-SQUAMOUS INTESTINAL METAPLASIA: EVIDENCE FROM STUDIES IN BARRETT’S PATIENTS AND ORGANOIDS
IN BARRETT’S ESOPHAGUS, REFLUX INDUCES EMT THAT MIGHT UNDERLIE THE DEVELOPMENT OF SUB-SQUAMOUS INTESTINAL METAPLASIA: EVIDENCE FROM STUDIES IN BARRETT’S PATIENTS AND ORGANOIDS
BACKGROUND: Barrett’s Esophagus (BE) develops after reflux-mediated injury to distal esophagus and is only known precursor of esophageal adenocarcinoma (EAC), a highly deadly and increasingly prevalent cancer…
Thumbnail for AGA Tadataka "Tachi" Yamada, MD, Lecture: Determining When Gastroesophageal Reflux Is the Culprit
AGA Tadataka "Tachi" Yamada, MD, Lecture: Determining When Gastroesophageal Reflux Is the Culprit
This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice…